Robecosam AG raised its holdings in shares of Albemarle Co. (NYSE:ALB) by 19.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 187,000 shares of the specialty chemicals company’s stock after purchasing an additional 30,200 shares during the quarter. Albemarle makes up 1.6% of Robecosam AG’s holdings, making the stock its 14th biggest position. Robecosam AG owned about 0.17% of Albemarle worth $24,020,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. SeaCrest Wealth Management LLC bought a new position in Albemarle during the 4th quarter worth $103,000. Stephens Inc. AR bought a new position in Albemarle during the 4th quarter worth $115,000. Valeo Financial Advisors LLC bought a new position in Albemarle during the 4th quarter worth $155,000. Renaissance Investment Group LLC bought a new position in Albemarle during the 4th quarter worth $201,000. Finally, Argent Trust Co bought a new position in Albemarle during the 3rd quarter worth $215,000. 86.42% of the stock is owned by institutional investors and hedge funds.
Albemarle Co. (NYSE:ALB) opened at $101.76 on Monday. Albemarle Co. has a 12-month low of $90.49 and a 12-month high of $144.99. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.06 and a quick ratio of 1.57. The stock has a market capitalization of $11,258.56, a PE ratio of 212.00, a price-to-earnings-growth ratio of 1.22 and a beta of 1.60.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Shareholders of record on Thursday, March 15th will be given a $0.335 dividend. This represents a $1.34 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Wednesday, March 14th. This is a boost from Albemarle’s previous quarterly dividend of $0.32. Albemarle’s payout ratio is currently 266.67%.
Several research analysts have weighed in on the company. Loop Capital set a $130.00 price objective on Albemarle and gave the stock a “buy” rating in a research report on Friday, March 2nd. SunTrust Banks increased their price objective on Albemarle to $110.00 and gave the stock a “hold” rating in a research report on Thursday, March 1st. Berenberg Bank assumed coverage on Albemarle in a research report on Tuesday, February 27th. They set a “buy” rating and a $150.00 price objective on the stock. KeyCorp reiterated an “overweight” rating and set a $148.00 price objective (down previously from $150.00) on shares of Albemarle in a research report on Thursday, March 1st. Finally, TheStreet cut Albemarle from a “b” rating to a “c+” rating in a research report on Tuesday, February 27th. Eight analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $128.07.
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.